Author

Imerio Angriman

MACROPHAGES ACTIVATION IN NEWLY DIAGNOSED ILEOCOLONIC CROHN’S DISEASE
MACROPHAGES ACTIVATION IN NEWLY DIAGNOSED ILEOCOLONIC CROHN’S DISEASE

Imerio Angriman  et al.

METACHRONOUS COLORECTAL CANCER HAVE SIMILAR MSI FREQUENCY BUT HIGHER FREQUENCY OF ABSENT LYMPHOMONOCYTES INFILTRATION THAN PRIMARY ONES
METACHRONOUS COLORECTAL CANCER HAVE SIMILAR MSI FREQUENCY BUT HIGHER FREQUENCY OF ABSENT LYMPHOMONOCYTES INFILTRATION THAN PRIMARY ONES

Imerio Angriman  et al.

IMPACT ON QUALITY OF LIFE OF SETON PLACING IN PERIANAL CROHN'S DISEASE
IMPACT ON QUALITY OF LIFE OF SETON PLACING IN PERIANAL CROHN'S DISEASE

Imerio Angriman  et al.

SHORT DISEASE DURATION AND SUPERFICIAL PENETRATION WITHIN THE ILEAL WALL ARE ASSOCIATED TO M1 MACROPHAGES INFILTRATION AND ACTIVATION IN ILEOCOLONIC CROHN´S DISEASE
SHORT DISEASE DURATION AND SUPERFICIAL PENETRATION WITHIN THE ILEAL WALL ARE ASSOCIATED TO M1 MACROPHAGES INFILTRATION AND ACTIVATION IN ILEOCOLONIC CROHN´S DISEASE

Imerio Angriman  et al.

IMMUNOLOGICAL MICROENVIRONMENT IN RECTAL ADENOCARCINOMA TREATMENT (IMMUNOREACT) PRELIMINARY RESULTS: HIGH PD-L1+ CELL INFILTRATION IN HEALTHY MUCOSA IS ASSOCIATED TO NODAL METASTASIS IN EARLY RECTAL CANCER
IMMUNOLOGICAL MICROENVIRONMENT IN RECTAL ADENOCARCINOMA TREATMENT (IMMUNOREACT) PRELIMINARY RESULTS: HIGH PD-L1+ CELL INFILTRATION IN HEALTHY MUCOSA IS ASSOCIATED TO NODAL METASTASIS IN EARLY RECTAL CANCER

Imerio Angriman  et al.

LOW DOSE ASPIRIN IS ASSOCIATED TO A LOWER FREQUENCY OF NODAL METASTASIS IN COLORECTAL CANCER
LOW DOSE ASPIRIN IS ASSOCIATED TO A LOWER FREQUENCY OF NODAL METASTASIS IN COLORECTAL CANCER

Imerio Angriman  et al.

IMMUNOLOGICAL MICROENVIRONMENT IN RECTAL ADENOCARCINOMA TREATMENT (IMMUNOREACT) PRELIMINARY RESULTS: T CELL INFILTRATION OF HEALTHY RECTAL MUCOSA AFTER COMPLETE RESPONSE TO NEOADJUVANT THERAPY IS SIGNIFICANTLY LOWER IN MALES
IMMUNOLOGICAL MICROENVIRONMENT IN RECTAL ADENOCARCINOMA TREATMENT (IMMUNOREACT) PRELIMINARY RESULTS: T CELL INFILTRATION OF HEALTHY RECTAL MUCOSA AFTER COMPLETE RESPONSE TO NEOADJUVANT THERAPY IS SIGNIFICANTLY LOWER IN MALES

Imerio Angriman  et al.

IMMUNOREACT 0: BIOPSY-BASED IMMUNE BIOMARKERS AS PREDICTORS OF RESPONSE TO NEOADJUVANT THERAPY FOR RECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
IMMUNOREACT 0: BIOPSY-BASED IMMUNE BIOMARKERS AS PREDICTORS OF RESPONSE TO NEOADJUVANT THERAPY FOR RECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

Imerio Angriman  et al.

PERITUMORAL MICROENVIRONMENT AS A PREDICTOR OF ANASTOMOTIC LEAK AFTER SURGERY FOR RECTAL CANCER
PERITUMORAL MICROENVIRONMENT AS A PREDICTOR OF ANASTOMOTIC LEAK AFTER SURGERY FOR RECTAL CANCER

Imerio Angriman  et al.

DISTINCTIVE MICROBIOTA AND DENDRITIC CELL ACTIVATION CHARACTERIZE THE APPENDIX OF ULCERATIVE COLITIS PATIENTS
DISTINCTIVE MICROBIOTA AND DENDRITIC CELL ACTIVATION CHARACTERIZE THE APPENDIX OF ULCERATIVE COLITIS PATIENTS

Imerio Angriman  et al.

European evidence based consensus on surgery for ulcerative colitis
European evidence based consensus on surgery for ulcerative colitis

Imerio Angriman  et al.

Item 1 - 11 / 11
1